Last reviewed · How we verify
Placebo, Oral intake single dose
This drug has no known mechanism of action.
At a glance
| Generic name | Placebo, Oral intake single dose |
|---|---|
| Also known as | Sugar pills manufactured to mimick Sildenafil 100 mg |
| Sponsor | University Hospital, Angers |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not contain any active pharmaceutical ingredient and therefore does not have a known mechanism of action.
Approved indications
Common side effects
Key clinical trials
- Resistance Training Adaptations and Caffeine Intake (NA)
- Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease (NA)
- Multiple Ascending Dose Study of NH102 in Healthy Subjects (PHASE1)
- The Acute Interference of Biotin in Blood Analysis (NA)
- Effect of Vitamin D on Body Composition and Functionality of Older Adults (NA)
- Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive (PHASE3)
- Novel Combination Therapy for Osteoporosis in Men (PHASE4)
- A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo, Oral intake single dose CI brief — competitive landscape report
- Placebo, Oral intake single dose updates RSS · CI watch RSS
- University Hospital, Angers portfolio CI